The biopsy device market will experience considerable growth over the forecast period, driven by an increasing number of biopsy procedures. A heightened awareness of the importance of early disease detection is motivating physicians to perform more biopsies at earlier stages in patient treatment, so as to increase the probability of treatment success. Today, physicians are biopsying lower-risk patients more than they did in the past to confirm their diagnoses and avoid the potential for malpractice lawsuits. The aging population will also drive procedure volumes because advanced age is associated with an array of health complications, some of which necessitate a biopsy. The market will also expand in response to demand for convenient product capabilities, such as multiple firing distances, which bolster average selling prices.
